Back to Top
Alomfilimab Biosimilar - Research Grade
$710.00 - $6,900.00
Alomfilimab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
ICOSï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
Q9Y6W8
Shipping Conditions
Blue ice
Background
ICOS (inducible T-cell co-stimulator) is a co-stimulatory receptor that enhances T-cell activation and is studied across immunology and immuno-oncology research. Offered as an unconjugated, non-therapeutic analog of alomfilimab, this research-grade anti-human ICOS recombinant monoclonal antibody is intended for research use only. It is manufactured to in vivo quality standards, formulated for low endotoxin, and supplied in scalable milligram (mg) to gram (g) quantities for high-throughput and heavy-usage laboratories. Typical applications include co-stimulation and functional T-cell assays, in vitro screening, and in vivo immuno-oncology models requiring a consistent, reproducible reagent.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review














